61-75 of 131
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CENonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CEPractical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
FSGS in Practice: Patient-Centered Decision-Making
CME/CEFSGS in Practice: Patient-Centered Decision-Making
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
CME/CEInsights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
CME/CEPearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
- advertisement
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
CME/CEBreaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Unmasking IgAN: From Suspicion to Timely Diagnosis
CME/CEUnmasking IgAN: From Suspicion to Timely Diagnosis
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CEFinally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
- advertisement
ns-MRAs and eGFR Slope: The Kidney Perspective
MinuteCE®ns-MRAs and eGFR Slope: The Kidney Perspective
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
CME/CEOptimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines

















































































